Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2023/0671 - LETERMOVIR [240 MG CÁP/COMP]
Tender Description
LETERMOVIR [240 MG CÁP/COMP]
Iftaħ Għarfien Sħiħ dwar it-Tender
Id-dettalji u l-analiżi AI kollha huma disponibbli fuq tend.ee. Oħloq kont bla ħlas.
Bla ħlas biex tibda. Ebda karta tal-kreditu meħtieġa.
